Interestingly, CPT1 expression is also declared in CKD models, inducing lower mitochondrial ß-Ox activity (Yang et al. 2017; Aparicio-Trejo et al. 2020a, b; Gao and Chen 2022). This evidence concerns the gene CPT1A and chronic kidney disease.